Literature DB >> 19055170

Review of intravascular lymphoma with a report of treatment with allogenic peripheral blood stem cell transplant.

David N Adam1, Kathryn M Beleznay, Roop S Randhawa, Monica Marton, Youwen Zhou.   

Abstract

Intravascular lymphoma (IVL) is a non-Hodgkin lymphoma in which atypical lymphocytes accumulate within small blood vessels. Patients most commonly present with neurologic and cutaneous findings; however, any organ system may be affected, which leads to difficulties in diagnosis. The objectives of this article are to review the current IVL literature and stress the importance of multiple skin biopsies in diagnosis. We also describe, to our knowledge, the first case of IVL treated with allogenic peripheral blood stem cell transplant (PBSCT). Intravascular lymphoma should be considered in the differential diagnosis of unexplained erythematous tender indurated plaques, nodules, and telangiectases. Single biopsy is not sufficient to rule out this entity. Intravascular lymphoma is a recalcitrant malignancy, and we describe a case that quickly recurred after treatment with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab (CHOP-R), and necessitated allogenic bone marrow transplantation (BMT).

Entities:  

Mesh:

Year:  2008        PMID: 19055170

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  2 in total

1.  Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation.

Authors:  Yoko Miura; Jun Ooi; Takuji Matsuo; Tadashi Yamamoto; Ritsu Sumiyoshi; Sumiko Saito; Kensuke Matsumoto; Haruko Tashiro; Naoki Shirafuji
Journal:  Ann Hematol       Date:  2020-10-22       Impact factor: 3.673

2.  Asian-variant intravascular lymphoma in the African race.

Authors:  Holly Geyer; Nina Karlin; Brian Palen; Ruben Mesa
Journal:  Rare Tumors       Date:  2012-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.